tiprankstipranks
Trending News
More News >
Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE)
:ONE
Australian Market

Oneview Healthcare Chess Depository Interests repr 1 (ONE) Financial Statements

Compare
8 Followers

Oneview Healthcare Chess Depository Interests repr 1 Financial Overview

Oneview Healthcare Chess Depository Interests repr 1's market cap is currently AU$212.21M. The company's EPS TTM is AU$-0.026; its P/E ratio is ―; Oneview Healthcare Chess Depository Interests repr 1 is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is AU$-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 9.89M€ 9.40M€ 8.92M€ 9.73M€ 7.10M
Gross Profit€ 6.67M€ 6.16M€ 5.35M€ 5.31M€ 4.72M
Operating Income€ -11.36M€ -8.37M€ -10.76M€ -8.01M€ -8.23M
EBITDA€ -11.26M€ -7.88M€ -15.38M€ -7.42M€ -8.18M
Net Income€ -10.84M€ -8.93M€ -10.87M€ -8.19M€ -9.45M
Balance Sheet
Cash & Short-Term Investments€ 13.83M€ 11.55M€ 6.41M€ 15.18M€ 6.80M
Total Assets€ 25.96M€ 21.92M€ 12.75M€ 21.09M€ 14.25M
Total Debt€ 1.15M€ 935.32K€ 543.01K€ 1.20M€ 1.51M
Net Debt€ -12.68M€ -10.61M€ -5.87M€ -13.97M€ -5.29M
Total Liabilities€ 12.71M€ 12.78M€ 10.50M€ 11.19M€ 10.18M
Stockholders' Equity€ 13.25M€ 9.14M€ 2.26M€ 9.90M€ 4.07M
Cash Flow
Free Cash Flow€ -10.52M€ -7.79M€ -10.24M€ -4.09M€ -7.94M
Operating Cash Flow€ -10.47M€ -7.26M€ -10.20M€ -4.03M€ -7.69M
Investing Cash Flow€ -459.78K€ -521.38K€ -44.52K€ -65.26K€ -249.35K
Financing Cash Flow€ 13.14M€ 13.04M€ -100.11K€ 12.22M€ 4.95M
Currency in EUR

Oneview Healthcare Chess Depository Interests repr 1 Earnings and Revenue History

Oneview Healthcare Chess Depository Interests repr 1 Debt to Assets

Oneview Healthcare Chess Depository Interests repr 1 Cash Flow

Oneview Healthcare Chess Depository Interests repr 1 Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis